Clinical trial
A Clinical Biomarker Study of Immunological Phenotypes Associated With Monoaminergic Anti-depressant Response, and the Brain and Cognitive Phenotypes Associated With Variation in Peripheral C-reactive Protein (CRP) Levels, in Patients With Major Depressive Disorder (MDD).
NCT02752178 is registered in ClinicalTrials.gov with University of Cambridge as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Biomarker Study of Immunological Phenotypes Associated With Monoaminergic Anti-depressant Response, and the Brain and Cognitive Phenotypes Associated With Variation in Peripheral C-reactive Protein (CRP) Levels, in Patients With Major Depressive Disorder (MDD).
- Lead sponsor
- University of Cambridge
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2015
- Completion date
- September 30, 2018
- Enrollment
- 393 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
depressive disorder, major